PeptideStack
5.2kquestions
20kanswers
220users

orforglipron

Page 10 of 10 · 219 questions tagged orforglipron.

NewestActiveVotesUnanswered

219 questions · sorted by votes · page 10 of 10

2 votes3 answers6.4k views
Does constipation at week four of orforglipron usually resolve without a dose change?

Concretely: constipation · four · orforglipron. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…

constipation
constipation

Slowed transit as a consequence of delayed gastric emptying and reduced intake: incidence figures, fibre and hydration evidence, and why it often…

55 questionstitration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questionsorforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questionsasked by u100_marks 52k · 11 months ago
2 votes0 answers693 views
Would you accept 99.4% on orforglipron from GGPeps without a content assay?

What I have: 99.4% · orforglipron · GGPeps. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questionscontent-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

476 questionsvendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questionsorforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questionsasked by nynke_dekker 9.4k · 3 months ago
1 vote 4 answers3.6k views
Is orforglipron at 20 mg/mL stable enough for sixteen weeks of multi-withdrawal use?

Stated plainly: orforglipron · 20 mg/mL · sixteen weeks. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questionsbacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

149 questionsshelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

327 questionsorforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questionsasked by dmitri_savchuk 27k · 2 months ago